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Text: Background 
The UK CF registry analysis showed that people with prior high levels of rescue will often continue to need high levels of 
rescue. We hypothesised that low preventative nebuliser adherence is an important predictor for rescue IV use. The UK CF 
registry does not record adherence data. We therefor analyse I-neb® adherence data alongside IV use data from the 
Sheffield Adult CF centre. 
 
Methods 
Objective adherence was calculated for those with ≥3 months of I-neb® data. Those on ivacaftor were excluded. A tree-based 
method (Zhang & Bracken, AJE 1996) was used to divide the study sample into clinically meaningful subgroups based on 
results of the UK CF registry analysis. For each subgroup, IV use in 2013 & 2014 are compared among those with adherence 
≥80% vs < 80%. This cut-off for ´good adherence´ was based on previous studies. 
 
Results 




















































































































0 (0-15) 10 (0-14) 35 ** 25 (14-47) 7 ** 16 (14-32) 14 ** 41 (14-70)   
[IV use by group **Unable to calculate SD /  IQR] 
 
Those with worsening FEV1 / increasing IV days resulting in worsening of their clinical subgroup from 2013 to 2014 (n=16) 
have lower adherence in 2013 compared to those who remained stable / improved (n=71); mean 22% (95% CI 12-33%) vs 
40% (95% CI 33-47%), p-value 0.007. 
 
Conclusion 
Nebuliser adherence is an important modifiable risk factor for high IV use. Those with high IV use may benefit from better 
nebuliser adherence. 
 
